What is Flashback Technologies?
Flashback Technologies operates at the intersection of advanced machine learning and clinical diagnostics. The company specializes in the synthesis of fragmented medical data into actionable intelligence, a capability best exemplified by its flagship product, the CipherOx CRI-M1. This FDA-cleared blood loss monitor utilizes the Compensatory Reserve Index to provide real-time, trend-based insights into acute blood loss, offering a vital tool for healthcare providers and researchers alike.
Beyond its hardware offerings, the firm provides a comprehensive suite of solutions designed for operational optimization and regulatory support. By addressing the inherent challenges of data silos in clinical environments, Flashback Technologies empowers healthcare organizations to improve patient outcomes through enhanced analytical clarity. Their market position is defined by a commitment to rigorous scientific validation and the seamless integration of complex physiological data into standard clinical workflows.
How much funding has Flashback Technologies raised?
Flashback Technologies has raised a total of $3.5M across 2 funding rounds:
Series A
$2.3M
Private Equity
$1.2M
Series A (2014): $2.3M with participation from Pacific Advantage Capital
Private Equity (2016): $1.2M, investors not publicly disclosed
Key Investors in Flashback Technologies
Pacific Advantage Capital
Pacific Advantage Capital is a private investment partnership that focuses on special situations, private equity, and growth equity across global markets. The firm leverages extensive experience in capital structure management to identify and support companies with high potential for risk-adjusted returns.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Flashback Technologies?
With the support of its recent strategic investment, Flashback Technologies is well-positioned to accelerate the deployment of its analytical platforms across broader clinical environments. The company is expected to prioritize the expansion of its research and development initiatives, focusing on the next generation of predictive monitoring tools that leverage the Compensatory Reserve Index. As the healthcare industry continues to prioritize data-driven decision-making, Flashback Technologies is poised to capture additional market share by scaling its enterprise-level solutions to meet the evolving needs of global life-science teams and hospital networks. Future growth will likely center on deepening its regulatory footprint and enhancing the interoperability of its data intelligence systems within existing hospital infrastructure.
See full Flashback Technologies company page
